Showing results (481-490 of 619) with videos related to
Sort By:
Pageof 62
Antimicrobial Agents and Chemotherapy|May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept studyMikaela M Walker, Jason A Roberts, Yixuan Li, et al.Proceedings of the National Academy of Sciences of the United States of America|November 11, 1999
Inhibition of luciferase expression in transgenic Aedes aegypti mosquitoes by Sindbis virus expression of antisense luciferase RNAB W Johnson, K E Olson, T Allen-Miura, et al.Journal of Virology|October 29, 2025
Perturbed pediatric circulating metabolome in mild and severe dengue diseasePaul S Soma, Rebekah C Gullberg, Barbara Graham, et al.Emerging Infectious Diseases|August 2, 2003
Serologic evidence of West Nile virus infection in horses, Coahuila State, MexicoBradley J Blitvich, Ildefonso Fernandez-Salas, Juan F Contreras-Cordero, et al.Antimicrobial Agents and Chemotherapy|May 16, 2022
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill PatientsAaron J Heffernan, Fekade B Sime, Nilesh Kumta, et al.Antimicrobial Agents and Chemotherapy|October 21, 2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care UnitMohd H Abdul-Aziz, Azrin N Abd Rahman, Mohd-Basri Mat-Nor, et al.International Journal of Antimicrobial Agents|April 18, 2015
Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administrationJanattul-Ain Jamal, Darren M Roberts, Andrew A Udy, et al.The European Respiratory Journal|June 1, 1997
An evaluation of two aerosol delivery systems for rhDNaseP L Shah, S F Scott, D M Geddes, et al.Analytical and Bioanalytical Chemistry|January 4, 2022
Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samplesSuzanne L Parker, Steven C Wallis, Cheryl Fourie, et al.The Journal of Antimicrobial Chemotherapy|August 29, 2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesChandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, et al.Pageof 62